28.06.2014 Views

Autologous Bone Marrow Transplantation - Blog Science Connections

Autologous Bone Marrow Transplantation - Blog Science Connections

Autologous Bone Marrow Transplantation - Blog Science Connections

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

554 High-Dose Carmustine and <strong>Transplantation</strong> for Gliomas<br />

not give any specific information, and no criterion for a hypereosinophilic<br />

syndrome was found.<br />

Other Toxicities<br />

Irradiation was done as scheduled for 11 patients (2 patients in relapse<br />

had had anterior irradiation, and 2 patients could not tolerate the scheduled<br />

radiotherapy course). The patients' treatment tolerance was very good, and<br />

the classical cerebral edema often present at the beginning of treatment<br />

could be controlled readily with appropriate medications. However, one<br />

patient died 3 days after the end of the radiotherapy course in a sudden coma;<br />

the autopsy showed a cerebral hemorrhage, when platelet count was normal;<br />

the remaining part of the tumor was completely necrotic and no cerebral<br />

edema was found. This type of complication is well known and classical in<br />

cerebral irradiation.<br />

No major problems were recorded in the majority of patients after surgery,<br />

but this probably reflects a bias in selection of patients, who entered this<br />

protocol only when their performance status was good. One patient,<br />

however, became comatose and died of an immediate postoperative<br />

extradural hematoma.<br />

Altogether, three deaths (20%) of toxic reactions at 2, 3, and 6 months<br />

after completion of the whole treatment protocol were recorded. Only one<br />

(7%) was directly consecutive to the high dose of carmustine.<br />

Response<br />

As of November 15,1986, the median follow-up has been only 4 months,<br />

and only the feasibility of the protocol is reported here in detail.<br />

All patients, except three who died of toxic effects, had at least the same<br />

performance status before and after treatment (1 -1), and four patients initially<br />

scored as having grade 2 status became grade 1 after treatment.<br />

Histologic assays of the four patients treated with surgery after high-dose<br />

carmustine, showed remaining neoplastic cells. Even if complete remission<br />

was not fully achieved after the high-dose chemotherapy, however, additional<br />

tumor reduction as a result of spontaneous necrosis has been observed. In<br />

the patient who died of cerebrospinal hemorrhage, no residual tumor cells<br />

were noticed at autopsy.<br />

The 15 patients' survival is plotted in Figure 1. In addition to the three<br />

patients who died, one patient has been in relapse, as shown by CT scan<br />

changes, since day 90. The other patients are alive, disease-free, and have a<br />

stable performance status.<br />

DISCUSSION AND CONCLUSION<br />

The objective of this pilot study was to evaluate the feasibility, efficiency,<br />

and tolerance of a new protocol combining surgery, conventional poly-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!